1. Home
  2. NEUP vs NAAS Comparison

NEUP vs NAAS Comparison

Compare NEUP & NAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEUP
  • NAAS
  • Stock Information
  • Founded
  • NEUP 1996
  • NAAS 2019
  • Country
  • NEUP United States
  • NAAS China
  • Employees
  • NEUP N/A
  • NAAS N/A
  • Industry
  • NEUP
  • NAAS Other Specialty Stores
  • Sector
  • NEUP
  • NAAS Consumer Discretionary
  • Exchange
  • NEUP Nasdaq
  • NAAS Nasdaq
  • Market Cap
  • NEUP 10.3M
  • NAAS 9.0M
  • IPO Year
  • NEUP N/A
  • NAAS 2017
  • Fundamental
  • Price
  • NEUP $4.36
  • NAAS $3.69
  • Analyst Decision
  • NEUP Strong Buy
  • NAAS
  • Analyst Count
  • NEUP 2
  • NAAS 0
  • Target Price
  • NEUP $28.00
  • NAAS N/A
  • AVG Volume (30 Days)
  • NEUP 229.1K
  • NAAS 12.1K
  • Earning Date
  • NEUP 11-14-2025
  • NAAS 03-31-2026
  • Dividend Yield
  • NEUP N/A
  • NAAS N/A
  • EPS Growth
  • NEUP N/A
  • NAAS N/A
  • EPS
  • NEUP N/A
  • NAAS N/A
  • Revenue
  • NEUP $15,649,448.00
  • NAAS $21,817,052.00
  • Revenue This Year
  • NEUP N/A
  • NAAS $378.49
  • Revenue Next Year
  • NEUP N/A
  • NAAS N/A
  • P/E Ratio
  • NEUP N/A
  • NAAS N/A
  • Revenue Growth
  • NEUP N/A
  • NAAS N/A
  • 52 Week Low
  • NEUP $2.90
  • NAAS $1.96
  • 52 Week High
  • NEUP $21.40
  • NAAS $49.60
  • Technical
  • Relative Strength Index (RSI)
  • NEUP 36.38
  • NAAS 52.36
  • Support Level
  • NEUP $4.13
  • NAAS $3.21
  • Resistance Level
  • NEUP $4.59
  • NAAS $3.79
  • Average True Range (ATR)
  • NEUP 0.38
  • NAAS 0.21
  • MACD
  • NEUP 0.30
  • NAAS 0.01
  • Stochastic Oscillator
  • NEUP 22.94
  • NAAS 74.58

About NEUP Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder. The Company operates through a single operating and reportable segment focused on the discovery and development of allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need.

About NAAS NaaS Technology Inc.

Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators, a wide range of offline services that simplify the daily operations of charging station operators, and non-charging services such as food and beverage services to station operators.

Share on Social Networks: